Skip to main content
Top
Published in: Endocrine 2/2019

01-02-2019 | Original Article

Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population

Authors: Meshael M. Alswailem, Ohoud S. Alzahrani, Lamyaa Alghofaili, Ebtesam Qasem, Mai Almohanaa, Afaf Alsagheir, Bassam Bin Abbas, Najya A. Attia, Adnan Al Shaikh, Ali S. Alzahrani

Published in: Endocrine | Issue 2/2019

Login to get access

Abstract

Context and objectives

5-α reductase deficiency is a rare 46,XY disorder of sex development. We present detailed phenotypic and genotypic features of a cohort of 24 subjects from a highly consanguineous population of Saudi Arabia

Subjects and Methods

We studied the clinical presentation and hormonal profiles of 24 subjects diagnosed with 5-α reductase deficiency and performed genetic testing on DNA isolated from their peripheral blood using polymerase chain reaction and direct sequencing of the SRD5A2.

Results

All subjects had 46,XY karyotype and presented with atypical appearance of external genitalia ranging from clitoromegaly, micophallus with hypospadias, undescended testes to completely normally looking female genitalia. Thirteen (54%) of them had severe under virilization and were assigned female sex at birth. The other 11 subjects were raised as males. Stimulated Testosterone:Dihydrotestosterone ratio was high in all 16 subjects in whom it was measured. The genetic testing revealed 2 nonsense mutations (p.R103X and p.R227X) in 2 unrelated subjects, 3 missense mutations (p.P181L, p.A228T, p.R246Q) in 11 subjects and a splice site mutation (IVS1-2A > G) in 11 other subjects. There was significant phenotypic variability even in subjects with the same mutation and also within the same family.

Conclusion

This is the first and largest report of the clinical and molecular genetics of 5-α reductase deficiency from the Middle East. It shows weak genotype/phenotype correlation and significant phenotypic heterogeneity. IVS1-2A > G mutation is the most common mutation and is likely to be a founder mutation in this part of the world.
Literature
1.
go back to reference J. Imperato-McGinley, L. Guerrero, T. Gautier, R.E. Peterson, Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186(4170), 1213–1215 (1974)CrossRef J. Imperato-McGinley, L. Guerrero, T. Gautier, R.E. Peterson, Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186(4170), 1213–1215 (1974)CrossRef
3.
go back to reference L. Maimoun, P. Philibert, B. Cammas, F. Audran, P. Bouchard, P. Fenichel, M. Cartigny, C. Pienkowski, M. Polak, N. Skordis, I. Mazen, G. Ocal, M. Berberoglu, R. Reynaud, C. Baumann, S. Cabrol, D. Simon, K. Kayemba-Kay’s, M. De Kerdanet, F. Kurtz, B. Leheup, C. Heinrichs, S. Tenoutasse, G. Van Vliet, A. Gruters, M. Eunice, A.C. Ammini, M. Hafez, Z. Hochberg, S. Einaudi, H. Al Mawlawi, C.J. Nunez, N. Servant, S. Lumbroso, F. Paris, C. Sultan, Phenotypical, biological, and molecular heterogeneity of 5alpha-reductase deficiency: an extensive international experience of 55 patients. J. Clin. Endocrinol. Metab. 96(2), 296–307 (2011). https://doi.org/10.1210/jc.2010-1024 CrossRefPubMed L. Maimoun, P. Philibert, B. Cammas, F. Audran, P. Bouchard, P. Fenichel, M. Cartigny, C. Pienkowski, M. Polak, N. Skordis, I. Mazen, G. Ocal, M. Berberoglu, R. Reynaud, C. Baumann, S. Cabrol, D. Simon, K. Kayemba-Kay’s, M. De Kerdanet, F. Kurtz, B. Leheup, C. Heinrichs, S. Tenoutasse, G. Van Vliet, A. Gruters, M. Eunice, A.C. Ammini, M. Hafez, Z. Hochberg, S. Einaudi, H. Al Mawlawi, C.J. Nunez, N. Servant, S. Lumbroso, F. Paris, C. Sultan, Phenotypical, biological, and molecular heterogeneity of 5alpha-reductase deficiency: an extensive international experience of 55 patients. J. Clin. Endocrinol. Metab. 96(2), 296–307 (2011). https://​doi.​org/​10.​1210/​jc.​2010-1024 CrossRefPubMed
13.
go back to reference M.I. El-Mouzan, A.A. Al-Salloum, A.S. Al-Herbish, M.M. Qurachi, A.A. Al-Omar, Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi. Med. J. 28(12), 1881–1884 (2007)PubMed M.I. El-Mouzan, A.A. Al-Salloum, A.S. Al-Herbish, M.M. Qurachi, A.A. Al-Omar, Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi. Med. J. 28(12), 1881–1884 (2007)PubMed
15.
go back to reference N. Skordis, P.C. Patsalis, I. Bacopoulou, C. Sismani, C. Sultan, S. Lumbroso, 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect. J. Pediatr. Endocrinol. & Metab.: JPEM 18(3), 241–246 (2005) N. Skordis, P.C. Patsalis, I. Bacopoulou, C. Sismani, C. Sultan, S. Lumbroso, 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect. J. Pediatr. Endocrinol. & Metab.: JPEM 18(3), 241–246 (2005)
16.
go back to reference G. Ocal, P. Adiyaman, M. Berberoglu, E. Cetinkaya, N. Akar, A. Uysal, T. Duman, O. Evliyaoglu, Z. Aycan, S. Lumbroso, C. Sultan, Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J. Pediatr. Endocrinol. & Metab.: JPEM 15(4), 411–421 (2002)CrossRef G. Ocal, P. Adiyaman, M. Berberoglu, E. Cetinkaya, N. Akar, A. Uysal, T. Duman, O. Evliyaoglu, Z. Aycan, S. Lumbroso, C. Sultan, Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J. Pediatr. Endocrinol. & Metab.: JPEM 15(4), 411–421 (2002)CrossRef
17.
go back to reference C. Shammas, V. Neocleous, M. Toumba, C. Costi, A.A. Phedonos, E. Efstathiou, A. Kyriakou, L.A. Phylactou, N. Skordis, Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect. Genet. Test. Mol. Biomark. 16(9), 1073–1079 (2012). https://doi.org/10.1089/gtmb.2011.0381 CrossRef C. Shammas, V. Neocleous, M. Toumba, C. Costi, A.A. Phedonos, E. Efstathiou, A. Kyriakou, L.A. Phylactou, N. Skordis, Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect. Genet. Test. Mol. Biomark. 16(9), 1073–1079 (2012). https://​doi.​org/​10.​1089/​gtmb.​2011.​0381 CrossRef
18.
go back to reference O. Hiort, S.M. Schutt, M. Bals-Pratsch, P.M. Holterhus, C. Marschke, D. Struve, A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. Int. J. Androl. 25(1), 55–58 (2002)CrossRef O. Hiort, S.M. Schutt, M. Bals-Pratsch, P.M. Holterhus, C. Marschke, D. Struve, A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency. Int. J. Androl. 25(1), 55–58 (2002)CrossRef
19.
go back to reference E. Simsek, C. Binay, S. Ceylaner, The earlier described mutation (c.307c>T [p.R103X]) in the SRD5A2 gene causing a 46,XY female phenotype. J. Pediatr. Endocrinol. & Metab.: JPEM 25(5-6), 543–545 (2012)CrossRef E. Simsek, C. Binay, S. Ceylaner, The earlier described mutation (c.307c>T [p.R103X]) in the SRD5A2 gene causing a 46,XY female phenotype. J. Pediatr. Endocrinol. & Metab.: JPEM 25(5-6), 543–545 (2012)CrossRef
20.
go back to reference S.F. Ahmed, O. Khwaja, I.A. Hughes, The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 85(1), 120–124 (2000)CrossRef S.F. Ahmed, O. Khwaja, I.A. Hughes, The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 85(1), 120–124 (2000)CrossRef
21.
go back to reference S. Eggers, S. Sadedin, J.A. van den Bergen, G. Robevska, T. Ohnesorg, J. Hewitt, L. Lambeth, A. Bouty, I.M. Knarston, T.Y. Tan, F. Cameron, G. Werther, J. Hutson, M. O’Connell, S.R. Grover, Y. Heloury, M. Zacharin, P. Bergman, C. Kimber, J. Brown, N. Webb, M.F. Hunter, S. Srinivasan, A. Titmuss, C.F. Verge, D. Mowat, G. Smith, J. Smith, L. Ewans, C. Shalhoub, P. Crock, C. Cowell, G.M. Leong, M. Ono, A.R. Lafferty, T. Huynh, U. Visser, C.S. Choong, F. McKenzie, N. Pachter, E.M. Thompson, J. Couper, A. Baxendale, J. Gecz, B.J. Wheeler, C. Jefferies, K. MacKenzie, P. Hofman, P. Carter, R.I. King, C. Krausz, C.M. van Ravenswaaij-Arts, L. Looijenga, S. Drop, S. Riedl, M. Cools, A. Dawson, A.Z. Juniarto, V. Khadilkar, A. Khadilkar, V. Bhatia, V.C. Dung, I. Atta, J. Raza, N. Thi Diem Chi, T.K. Hao, V. Harley, P. Koopman, G. Warne, S. Faradz, A. Oshlack, K.L. Ayers, A.H. Sinclair, Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 17(1), 243 (2016). https://doi.org/10.1186/s13059-016-1105-y CrossRefPubMedPubMedCentral S. Eggers, S. Sadedin, J.A. van den Bergen, G. Robevska, T. Ohnesorg, J. Hewitt, L. Lambeth, A. Bouty, I.M. Knarston, T.Y. Tan, F. Cameron, G. Werther, J. Hutson, M. O’Connell, S.R. Grover, Y. Heloury, M. Zacharin, P. Bergman, C. Kimber, J. Brown, N. Webb, M.F. Hunter, S. Srinivasan, A. Titmuss, C.F. Verge, D. Mowat, G. Smith, J. Smith, L. Ewans, C. Shalhoub, P. Crock, C. Cowell, G.M. Leong, M. Ono, A.R. Lafferty, T. Huynh, U. Visser, C.S. Choong, F. McKenzie, N. Pachter, E.M. Thompson, J. Couper, A. Baxendale, J. Gecz, B.J. Wheeler, C. Jefferies, K. MacKenzie, P. Hofman, P. Carter, R.I. King, C. Krausz, C.M. van Ravenswaaij-Arts, L. Looijenga, S. Drop, S. Riedl, M. Cools, A. Dawson, A.Z. Juniarto, V. Khadilkar, A. Khadilkar, V. Bhatia, V.C. Dung, I. Atta, J. Raza, N. Thi Diem Chi, T.K. Hao, V. Harley, P. Koopman, G. Warne, S. Faradz, A. Oshlack, K.L. Ayers, A.H. Sinclair, Disorders of sex development: insights from targeted gene sequencing of a large international patient cohort. Genome Biol. 17(1), 243 (2016). https://​doi.​org/​10.​1186/​s13059-016-1105-y CrossRefPubMedPubMedCentral
22.
go back to reference L. Johnson, F.W. George, W.B. Neaves, I.M. Rosenthal, R.A. Christensen, A. Decristoforo, H.-U. Schweikert, M.V. Sauer, M. Leshin, J.E. Griffin, J.D. Wilson, Characterization of the Testicular Abnormality in 5a-Reductase Deficiency*. J. Clin. Endocrinol. & Metab. 63(5), 1091–1099 (1986). https://doi.org/10.1210/jcem-63-5-1091 CrossRef L. Johnson, F.W. George, W.B. Neaves, I.M. Rosenthal, R.A. Christensen, A. Decristoforo, H.-U. Schweikert, M.V. Sauer, M. Leshin, J.E. Griffin, J.D. Wilson, Characterization of the Testicular Abnormality in 5a-Reductase Deficiency*. J. Clin. Endocrinol. & Metab. 63(5), 1091–1099 (1986). https://​doi.​org/​10.​1210/​jcem-63-5-1091 CrossRef
26.
go back to reference C.Y. Lee, C.W. Lam, C.C. Shek, Steroid 5alpha-reductase 2 deficiency in two generations of a non-consanguineous Chinese family. J. Pediatr. Endocrinol. Metab. 16(8), 1197–1201 (2003)PubMed C.Y. Lee, C.W. Lam, C.C. Shek, Steroid 5alpha-reductase 2 deficiency in two generations of a non-consanguineous Chinese family. J. Pediatr. Endocrinol. Metab. 16(8), 1197–1201 (2003)PubMed
28.
go back to reference F. Vilchis, J.P. Mendez, P. Canto, E. Lieberman, B. Chavez, Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin. Endocrinol. (Oxf.). 52(3), 383–387 (2000)CrossRef F. Vilchis, J.P. Mendez, P. Canto, E. Lieberman, B. Chavez, Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin. Endocrinol. (Oxf.). 52(3), 383–387 (2000)CrossRef
30.
go back to reference N. Skordis, V. Neocleous, A. Kyriakou, E. Efstathiou, A. Sertedaki, P. Philibert, L.A. Phylactou, S. Lumbroso, C. Sultan, The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5alpha reductase deficiency. J. Endocrinol. Invest. 33(11), 810–814 (2010)CrossRef N. Skordis, V. Neocleous, A. Kyriakou, E. Efstathiou, A. Sertedaki, P. Philibert, L.A. Phylactou, S. Lumbroso, C. Sultan, The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5alpha reductase deficiency. J. Endocrinol. Invest. 33(11), 810–814 (2010)CrossRef
Metadata
Title
Molecular genetics and phenotype/genotype correlation of 5-α reductase deficiency in a highly consanguineous population
Authors
Meshael M. Alswailem
Ohoud S. Alzahrani
Lamyaa Alghofaili
Ebtesam Qasem
Mai Almohanaa
Afaf Alsagheir
Bassam Bin Abbas
Najya A. Attia
Adnan Al Shaikh
Ali S. Alzahrani
Publication date
01-02-2019
Publisher
Springer US
Published in
Endocrine / Issue 2/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1767-1

Other articles of this Issue 2/2019

Endocrine 2/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.